MiniMed Group, Inc. Common Stock (MMED)vsResMed Inc (RMD)
MMED
MiniMed Group, Inc. Common Stock
$18.90
+3.39%
HEALTHCARE · Cap: $5.25B
RMD
ResMed Inc
$227.08
-2.52%
HEALTHCARE · Cap: $35.18B
Smart Verdict
WallStSmart Research — data-driven comparison
ResMed Inc generates 75% more annual revenue ($5.65B vs $3.22B). RMD leads profitability with a 27.0% profit margin vs -9.7%. RMD earns a higher WallStSmart Score of 65/100 (C+).
MMED
Hold37
out of 100
Grade: F
RMD
Buy65
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for MMED.
Margin of Safety
-21.2%
Fair Value
$214.26
Current Price
$227.08
$12.82 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Conservative balance sheet, low leverage
16.6% revenue growth
Strong operational efficiency at 30.9%
Safe zone — low bankruptcy risk
Every $100 of equity generates 23 in profit
Keeps 27 of every $100 in revenue as profit
Conservative balance sheet, low leverage
Generating 1.6B in free cash flow
Areas to Watch
0.0% earnings growth
ROE of 0.0% — below average capital efficiency
Operating margin of 0.5%
Negative free cash flow — burning cash
2.4% earnings growth
Comparative Analysis Report
WallStSmart ResearchBull Case : MMED
The strongest argument for MMED centers on Price/Book, Debt/Equity, Revenue Growth. Revenue growth of 16.6% demonstrates continued momentum.
Bull Case : RMD
The strongest argument for RMD centers on Operating Margin, Altman Z-Score, Return on Equity. Profitability is solid with margins at 27.0% and operating margin at 30.9%. PEG of 1.34 suggests the stock is reasonably priced for its growth.
Bear Case : MMED
The primary concerns for MMED are EPS Growth, Return on Equity, Operating Margin.
Bear Case : RMD
The primary concerns for RMD are EPS Growth.
Key Dynamics to Monitor
MMED profiles as a growth stock while RMD is a mature play — different risk/reward profiles.
MMED is growing revenue faster at 16.6% — sustainability is the question.
RMD generates stronger free cash flow (1.6B), providing more financial flexibility.
Monitor MEDICAL INSTRUMENTS & SUPPLIES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
RMD scores higher overall (65/100 vs 37/100), backed by strong 27.0% margins. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
MiniMed Group, Inc. Common Stock
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Minimed Group, Inc. is a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company is headquartered in Northridge, California.
ResMed Inc
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
ResMed is a San Diego, California-based medical equipment company. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea (such as CPAP devices and masks), chronic obstructive pulmonary disease (COPD), and other respiratory conditions.
Visit Website →Compare with Other MEDICAL INSTRUMENTS & SUPPLIES Stocks
Want to dig deeper into these stocks?